Skip to main content
NCBI home page
Journal of Epidemiology and Community Health logoLink to Journal of Epidemiology and Community Health
. 2001 May;55(5):356–363. doi: 10.1136/jech.55.5.356

Large decline in injecting drug use in Amsterdam, 1986-1998: explanatory mechanisms and determinants of injecting transitions

E J C van Ameijden 1, R Coutinho 1
PMCID: PMC1731889  PMID: 11297661

Abstract

OBJECTIVES—To study community wide trends in injecting prevalence and trends in injecting transitions, and determinants.
DESIGN—Open cohort study with follow up every four months (Amsterdam Cohort Study). Generalised estimating equations were used for statistical analysis.
SETTING—Amsterdam has adopted a harm reduction approach as drug policy.
PARTICIPANTS—996 drug users who were recruited from 1986 to 1998, mainly at methadone programmes, who paid 13 620 cohort visits.
MAIN RESULTS—The prevalence of injecting decreased exponentially (66% to 36% in four to six monthly periods). Selective mortality and migration could maximally explain 33% of this decline. Instead, injecting initiation linearly decreased (4.1% to 0.7% per visit), cessation exponentially increased (10.0% to 17.1%), and relapse linearly decreased (21.3% to 11.8%). Non-injecting cocaine use (mainly pre-cooked, comparable to crack) and heroin use strongly increased. Trends were not attributable to changes in the study sample.
CONCLUSIONS—Harm reduction, including large scale needle exchange programmes, does not lead to an increase in injecting drug use. The injecting decline seems mainly attributable to ecological factors (for example, drug culture and market). Prevention of injecting is possible and peer-based interventions may be effective. The consequences of the recent upsurge in crack use requires further study.


Keywords: substance abuse; surveillance; cohort studies

Full Text

The Full Text of this article is available as a PDF (162.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barrio G., De la Fuente L., Royuela L., Díaz A., Rodríguez-Artalejo F. Cocaine use among heroin users in Spain: the diffusion of crack and cocaine smoking. Spanish Group for the Study on the Route of Administration of Drugs. J Epidemiol Community Health. 1998 Mar;52(3):172–180. doi: 10.1136/jech.52.3.172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Crofts N., Louie R., Rosenthal D., Jolley D. The first hit: circumstances surrounding initiation into injecting. Addiction. 1996 Aug;91(8):1187–1196. doi: 10.1046/j.1360-0443.1996.918118710.x. [DOI] [PubMed] [Google Scholar]
  3. Darke S., Cohen J., Ross J., Hando J., Hall W. Transitions between routes of administration of regular amphetamine users. Addiction. 1994 Sep;89(9):1077–1083. doi: 10.1111/j.1360-0443.1994.tb02784.x. [DOI] [PubMed] [Google Scholar]
  4. Des Jarlais D. C., Casriel C., Friedman S. R., Rosenblum A. AIDS and the transition to illicit drug injection--results of a randomized trial prevention program. Br J Addict. 1992 Mar;87(3):493–498. doi: 10.1111/j.1360-0443.1992.tb01950.x. [DOI] [PubMed] [Google Scholar]
  5. Des Jarlais D. C., Friedman S. R., Sotheran J. L., Wenston J., Marmor M., Yancovitz S. R., Frank B., Beatrice S., Mildvan D. Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992. JAMA. 1994 Jan 12;271(2):121–127. [PubMed] [Google Scholar]
  6. Diaz T., Chu S. Y., Byers R. H., Jr, Hersh B. S., Conti L., Rietmeijer C. A., Mokotoff E., Fann S. A., Boyd D., Iglesias L. The types of drugs used by HIV-infected injection drug users in a multistate surveillance project: implications for intervention. Am J Public Health. 1994 Dec;84(12):1971–1975. doi: 10.2105/ajph.84.12.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dinwiddie S. H., Reich T., Cloninger C. R. Lifetime complications of drug use in intravenous drug users. J Subst Abuse. 1992;4(1):13–18. doi: 10.1016/0899-3289(92)90023-q. [DOI] [PubMed] [Google Scholar]
  8. Drucker E., Lurie P., Wodak A., Alcabes P. Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV. AIDS. 1998;12 (Suppl A):S217–S230. [PubMed] [Google Scholar]
  9. Fennema J. S., Van Ameijden E. J., Van Den Hoek A., Coutinho R. A. Young and recent-onset injecting drug users are at higher risk for HIV. Addiction. 1997 Nov;92(11):1457–1465. [PubMed] [Google Scholar]
  10. Fischer B., Kendall P., Rehm J., Room R. Charting WHO--goals for licit and illicit drugs for the year 2000: are we 'on track'? Public Health. 1997 Sep;111(5):271–275. doi: 10.1038/sj.ph.1900391. [DOI] [PubMed] [Google Scholar]
  11. Garfein R. S., Vlahov D., Galai N., Doherty M. C., Nelson K. E. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health. 1996 May;86(5):655–661. doi: 10.2105/ajph.86.5.655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Griffiths P., Gossop M., Powis B., Strang J. Extent and nature of transitions of route among heroin addicts in treatment--preliminary data from the Drug Transitions Study. Br J Addict. 1992 Mar;87(3):485–491. doi: 10.1111/j.1360-0443.1992.tb01949.x. [DOI] [PubMed] [Google Scholar]
  13. Grund J. P., Adriaans N. F., Kaplan C. D. Changing cocaine smoking rituals in the Dutch heroin addict population. Br J Addict. 1991 Apr;86(4):439–448. doi: 10.1111/j.1360-0443.1991.tb03421.x. [DOI] [PubMed] [Google Scholar]
  14. Grund J. P., Stern L. S., Kaplan C. D., Adriaans N. F., Drucker E. Drug use contexts and HIV-consequences: the effect of drug policy on patterns of everyday drug use in Rotterdam and the Bronx. Br J Addict. 1992 Mar;87(3):381–392. doi: 10.1111/j.1360-0443.1992.tb01939.x. [DOI] [PubMed] [Google Scholar]
  15. Hartgers C., Van den Hoek A., Krijnen P., Van Brussel G. H., Coutinho R. A. Changes over time in heroin and cocaine use among injecting drug users in Amsterdam, The Netherlands, 1985-1989. Br J Addict. 1991 Sep;86(9):1091–1097. doi: 10.1111/j.1360-0443.1991.tb01876.x. [DOI] [PubMed] [Google Scholar]
  16. Hunter G. M., Donoghoe M. C., Stimson G. V. Crack use and injection on the increase among injecting drug users in London. Addiction. 1995 Oct;90(10):1397–1400. doi: 10.1046/j.1360-0443.1995.9010139711.x. [DOI] [PubMed] [Google Scholar]
  17. Irwin K. L., Edlin B. R., Faruque S., McCoy H. V., Word C., Serrano Y., Inciardi J., Bowser B., Holmberg S. D. Crack cocaine smokers who turn to drug injection: characteristics, factors associated with injection, and implications for HIV transmission. The Multicenter Crack Cocaine and HIV Infection Study Team. Drug Alcohol Depend. 1996 Oct;42(2):85–92. doi: 10.1016/0376-8716(96)01262-8. [DOI] [PubMed] [Google Scholar]
  18. Langendam M. W., van Brussel G. H., Coutinho R. A., van Ameijden E. J. Methadone maintenance and cessation of injecting drug use: results from the Amsterdam Cohort Study. Addiction. 2000 Apr;95(4):591–600. doi: 10.1046/j.1360-0443.2000.95459110.x. [DOI] [PubMed] [Google Scholar]
  19. Langendam M. W., van Haastrecht H. J., van Ameijden E. J. The validity of drug users' self-reports in a non-treatment setting: prevalence and predictors of incorrect reporting methadone treatment modalities. Int J Epidemiol. 1999 Jun;28(3):514–520. doi: 10.1093/ije/28.3.514. [DOI] [PubMed] [Google Scholar]
  20. Langendam M. W., van Haastrecht H. J., van Brussel G. H., Reurs H., van den Hoek A. A., Coutinho R. A., van Ameijden E. J. Differentiation in the Amsterdam methadone dispensing circuit: determinants of methadone dosage and site of methadone prescription. Addiction. 1998 Jan;93(1):61–72. doi: 10.1046/j.1360-0443.1998.931617.x. [DOI] [PubMed] [Google Scholar]
  21. Peters A. D., Reid M. M., Griffin S. G. Edinburgh drug users: are they injecting and sharing less? AIDS. 1994 Apr;8(4):521–528. [PubMed] [Google Scholar]
  22. Robertson J. R., Ronald P. J., Raab G. M., Ross A. J., Parpia T. Deaths, HIV infection, abstinence, and other outcomes in a cohort of injecting drug users followed up for 10 years. BMJ. 1994 Aug 6;309(6951):369–372. doi: 10.1136/bmj.309.6951.369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Schoenbaum E. E., Hartel D. M., Gourevitch M. N. Needle exchange use among a cohort of injecting drug users. AIDS. 1996 Dec;10(14):1729–1734. doi: 10.1097/00002030-199612000-00018. [DOI] [PubMed] [Google Scholar]
  24. Sibthorpe B., Lear B. Circumstances surrounding needle use transitions among injection drug users: implications for HIV intervention. Int J Addict. 1994 Aug;29(10):1245–1257. doi: 10.3109/10826089409047940. [DOI] [PubMed] [Google Scholar]
  25. Spijkerman I. J., van Ameijden E. J., Mientjes G. H., Coutinho R. A., van den Hoek A. Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users. J Clin Epidemiol. 1996 Oct;49(10):1149–1154. doi: 10.1016/0895-4356(96)00180-1. [DOI] [PubMed] [Google Scholar]
  26. Stiffman A. R., Doré P., Earls F., Cunningham R. The influence of mental health problems on AIDS-related risk behaviors in young adults. J Nerv Ment Dis. 1992 May;180(5):314–320. doi: 10.1097/00005053-199205000-00005. [DOI] [PubMed] [Google Scholar]
  27. Strathdee S. A., Patrick D. M., Currie S. L., Cornelisse P. G., Rekart M. L., Montaner J. S., Schechter M. T., O'Shaughnessy M. V. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 1997 Jul;11(8):F59–F65. doi: 10.1097/00002030-199708000-00001. [DOI] [PubMed] [Google Scholar]
  28. Strathdee S. A., van Ameijden E. J., Mesquita F., Wodak A., Rana S., Vlahov D. Can HIV epidemics among injection drug users be prevented? AIDS. 1998;12 (Suppl A):S71–S79. [PubMed] [Google Scholar]
  29. Van Ameijden E. J., Langendam M. W., Notenboom J., Coutinho R. A. Continuing injecting risk behaviour: results from the Amsterdam Cohort Study of drug users. Addiction. 1999 Jul;94(7):1051–1061. doi: 10.1046/j.1360-0443.1999.947105110.x. [DOI] [PubMed] [Google Scholar]
  30. Van Ameijden E. J., Van den Hoek J. A., Mientjes G. H., Coutinho R. A. A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam. Eur J Epidemiol. 1993 May;9(3):255–262. doi: 10.1007/BF00146260. [DOI] [PubMed] [Google Scholar]
  31. Watters J. K., Estilo M. J., Clark G. L., Lorvick J. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. JAMA. 1994 Jan 12;271(2):115–120. [PubMed] [Google Scholar]
  32. White J. M., Dyer K. R., Ali R. L., Gaughwin M. D., Cormack S. Injecting behaviour and risky needle use amongst methadone maintenance clients. Drug Alcohol Depend. 1994 Jan;34(2):113–119. doi: 10.1016/0376-8716(94)90131-7. [DOI] [PubMed] [Google Scholar]
  33. Wu Z., Detels R., Zhang J., Duan S., Cheng H., Li Z., Dong L., Huang S., Jia M., Bi X. Risk factors for intravenous drug use and sharing equipment among young male drug users in Longchuan County, south-west China. AIDS. 1996 Aug;10(9):1017–1024. doi: 10.1097/00002030-199610090-00013. [DOI] [PubMed] [Google Scholar]
  34. Zeger S. L., Liang K. Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986 Mar;42(1):121–130. [PubMed] [Google Scholar]
  35. de la Fuente L., Barrio G., Royuela L., Bravo M. J. The transition from injecting to smoking heroin in three Spanish cities. The Spanish Group for the Study of the Route of Heroin Administration. Addiction. 1997 Dec;92(12):1749–1763. [PubMed] [Google Scholar]
  36. de la Fuente L., Saavedra P., Barrio G., Royuela L., Vicente J. Temporal and geographic variations in the characteristics of heroin seized in Spain and their relation with the route of administration. Spanish Group for the Study of the Purity of Seized Drugs. Drug Alcohol Depend. 1996 Mar;40(3):185–194. doi: 10.1016/0376-8716(95)01208-7. [DOI] [PubMed] [Google Scholar]
  37. van Ameijden E. J., Coutinho R. A. Maximum impact of HIV prevention measures targeted at injecting drug users. AIDS. 1998 Apr 16;12(6):625–633. doi: 10.1097/00002030-199806000-00012. [DOI] [PubMed] [Google Scholar]
  38. van Ameijden E. J., Watters J. K., van den Hoek J. A., Coutinho R. A. Interventions among injecting drug users: do they work? AIDS. 1995;9 (Suppl A):S75–S84. [PubMed] [Google Scholar]
  39. van Ameijden E. J., van den Hoek J. A., Hartgers C., Coutinho R. A. Risk factors for the transition from noninjection to injection drug use and accompanying AIDS risk behavior in a cohort of drug users. Am J Epidemiol. 1994 Jun 15;139(12):1153–1163. doi: 10.1093/oxfordjournals.aje.a116962. [DOI] [PubMed] [Google Scholar]
  40. van Ameijden E. J., van den Hoek J. A., van Haastrecht H. J., Coutinho R. A. The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injecting drug users, Amsterdam. Am J Epidemiol. 1992 Jul 15;136(2):236–243. doi: 10.1093/oxfordjournals.aje.a116489. [DOI] [PubMed] [Google Scholar]
  41. van Haastrecht H. J., van Ameijden E. J., van den Hoek J. A., Mientjes G. H., Bax J. S., Coutinho R. A. Predictors of mortality in the Amsterdam cohort of human immunodeficiency virus (HIV)-positive and HIV-negative drug users. Am J Epidemiol. 1996 Feb 15;143(4):380–391. doi: 10.1093/oxfordjournals.aje.a008752. [DOI] [PubMed] [Google Scholar]
  42. van der Werf M. J., van Benthem B. H., van Ameijden E. J. Prevalence, incidence and risk factors of anaemia in HIV-positive and HIV-negative drug users. Addiction. 2000 Mar;95(3):383–392. doi: 10.1046/j.1360-0443.2000.9533839.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Epidemiology and Community Health are provided here courtesy of BMJ Publishing Group

RESOURCES